Cargando…
Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study
BACKGROUND/PURPOSE: The Asian Liver Radiation Therapy Study Group has formed a large and detailed multinational database of outcomes following stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC). Here, we explored the potential impact of HCC etiology on SBRT efficacy. Tumor...
Autores principales: | Kim, Nalee, Cheng, Jason Chia-Hsien, Ohri, Nitin, Huang, Wen-Yen, Kimura, Tomoki, Zeng, Zhao Chong, Lee, Victor Ho Fun, Kay, Chul Seung, Seong, Jinsil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364984/ https://www.ncbi.nlm.nih.gov/pubmed/35966184 http://dx.doi.org/10.2147/JHC.S377810 |
Ejemplares similares
-
Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure
por: Kim, Nalee, et al.
Publicado: (2022) -
The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
por: Kimura, Tomoki, et al.
Publicado: (2022) -
Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022) -
Correction to: Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022) -
Assessment of biological dosimetric margin for stereotactic body radiation therapy
por: Kawahara, Daisuke, et al.
Publicado: (2020)